APR 16, 2019 09:18 AM PDT

Drug Reduces Risk of Kidney Failure in Type 2 Diabetics

WRITTEN BY: Nouran Amin

A recent breakthrough clinical trial involving 4,401 participants in 34 countries revealed that a particular drug--canagliflozin, for Type 2 diabetics, lowered the risk of kidney failure and kidney disease. The trial, known as CREDENCE, also revealed that canagliflozin reduced the risk of major cardiovascular events. Findings of the CREDENCE trial were published in The New England Journal of Medicine.

"For the first time in 18 years, we have a therapy for patients with Type 2 diabetes and chronic kidney disease that decreases kidney failure," said Kenneth Mahaffey, MD, professor of medicine at the Stanford University School of Medicine and co-principal investigator of the trial. "Now, patients with diabetes have a promising option to guard against one of the most severe risks of their condition."

Canagliflozin is currently the only FDA approved therapeutic to protect kidney function in people with Type 2 diabetes as well as to reduce their risk of major adverse cardiovascular events. The drug works by increasing the excretion of glucose through the kidneys. It has already been approved by the Food and Drug Administration to lower blood glucose in patients with Type 2 diabetes and to reduce the risk of major adverse cardiovascular events in patients with Type 2 diabetes and existing heart disease.

"A drug like canagliflozin that improves both cardiovascular and renal outcomes has been eagerly sought by both patients with Type 2 diabetes and clinicians caring for them," Mahaffey said.

Individuals living with diabetes are prone to developing kidney disease due to prolonged high blood sugar which harms the blood vessels in the kidney. Additionally, diabetes can lead to high blood pressure, which stretches and weaken blood vessels in the organ.

Learn more on how diabetes can affect the kidneys: 

"People with diabetes and kidney disease are at extremely high risk of kidney failure, heart attack, stroke and death," says lead author of the study, Vlado Perkovic, MBBS, PhD, who is also the executive director of The George Institute for Global Health Australia and a professor of medicine at the University of New South Wales in Sydney. "With this definitive trial result, we now have a very effective way to reduce this risk using a once-daily pill."

Source: Stanford Medicine

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 10, 2019
Genetics & Genomics
DEC 10, 2019
Breast Cancer Drug Increases Survival for Prostate Cancer Patients
A breast cancer drug is better at treating advanced prostate cancer in some men than current therapies, a clinical trial shows....
DEC 10, 2019
Drug Discovery & Development
DEC 10, 2019
Tailor-made Drug for Girl with Rare Genetic Disease
Researchers have used personalized medicine to develop a tailor-made genetic treatment for a girl diagnosed with a rare genetic disease known as Batten dis...
DEC 10, 2019
Drug Discovery & Development
DEC 10, 2019
Diabetes: The next-generation therapy
A publication in Nature Communications describes a therapeutic that can avoid the side-effects of insulin in diabetic treatments particularly hypoglycemia....
DEC 10, 2019
Drug Discovery & Development
DEC 10, 2019
Cone Snail Venom Became and Pain Therapeutics
Ever heard of conotoxins? They are bioactive peptides present in the venom of the predatory marine cone snails that are well known for their effective enve...
DEC 10, 2019
Drug Discovery & Development
DEC 10, 2019
Vaccine Causes More Polio Cases than Wild Virus
The World Health Organization (WHO) has confirmed that 11 new cases of polio in five African countries including Nigeria, Congo and Angola were caused by a...
DEC 10, 2019
Drug Discovery & Development
DEC 10, 2019
New Ultrasound Treatment for Parkinson's Tremors
A non-invasive ultrasound procedure may provide lasting relief from tremors in people with Parkinson’s disease (PD) and essential tremor (ET), accord...
Loading Comments...